{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Dodécan-1-ol : Questions médicales les plus fréquentes",
"headline": "Dodécan-1-ol : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Dodécan-1-ol : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-22",
"dateModified": "2025-05-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Dodécan-1-ol"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Alcools gras",
"url": "https://questionsmedicales.fr/mesh/D005233",
"about": {
"@type": "MedicalCondition",
"name": "Alcools gras",
"code": {
"@type": "MedicalCode",
"code": "D005233",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.289"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dodécyl-sulfate de sodium",
"alternateName": "Sodium Dodecyl Sulfate",
"url": "https://questionsmedicales.fr/mesh/D012967",
"about": {
"@type": "MedicalCondition",
"name": "Dodécyl-sulfate de sodium",
"code": {
"@type": "MedicalCode",
"code": "D012967",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.289.220.720"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Dodécan-1-ol",
"alternateName": "Dodecanol",
"code": {
"@type": "MedicalCode",
"code": "D007851",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Y Yamaguchi",
"url": "https://questionsmedicales.fr/author/Y%20Yamaguchi",
"affiliation": {
"@type": "Organization",
"name": "Graduate School of Science, Osaka City University, Osaka, Japan."
}
},
{
"@type": "Person",
"name": "A Ogita",
"url": "https://questionsmedicales.fr/author/A%20Ogita",
"affiliation": {
"@type": "Organization",
"name": "Graduate School of Science, Osaka City University, Osaka, Japan."
}
},
{
"@type": "Person",
"name": "T Tanaka",
"url": "https://questionsmedicales.fr/author/T%20Tanaka",
"affiliation": {
"@type": "Organization",
"name": "Graduate School of Science, Osaka City University, Osaka, Japan."
}
},
{
"@type": "Person",
"name": "Antonela Ananiadou",
"url": "https://questionsmedicales.fr/author/Antonela%20Ananiadou",
"affiliation": {
"@type": "Organization",
"name": "Department of Physics, University of Ioannina, P.O. Box 1186, 451 10 Ioannina, Greece."
}
},
{
"@type": "Person",
"name": "George Papamokos",
"url": "https://questionsmedicales.fr/author/George%20Papamokos",
"affiliation": {
"@type": "Organization",
"name": "Department of Physics, University of Ioannina, P.O. Box 1186, 451 10 Ioannina, Greece."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Evolution of Neuroimaging Technologies to Evaluate Neural Activity Related to Knee Pain and Injury Risk.",
"datePublished": "2023-12-18",
"url": "https://questionsmedicales.fr/article/38109007",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12178-023-09877-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assisted reproductive technology induces different secondary sex ratio: parental and embryonic impacts.",
"datePublished": "2023-12-14",
"url": "https://questionsmedicales.fr/article/38097997",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12978-023-01723-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of digital assistive technologies on the quality of life for people with dementia: protocol for a scoping review.",
"datePublished": "2023-12-13",
"url": "https://questionsmedicales.fr/article/38097237",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2023-077017"
}
},
{
"@type": "ScholarlyArticle",
"name": "STIC-HD live flow technology in the antenatal diagnosis of scimitar syndrome: A case report.",
"datePublished": "2023-12-13",
"url": "https://questionsmedicales.fr/article/38088486",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/echo.15720"
}
},
{
"@type": "ScholarlyArticle",
"name": "Feasibility of an eye-gaze technology intervention for students with severe motor and communication difficulties in Taiwan.",
"datePublished": "2023-12-12",
"url": "https://questionsmedicales.fr/article/38085526",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/07434618.2023.2288837"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Lipides",
"item": "https://questionsmedicales.fr/mesh/D008055"
},
{
"@type": "ListItem",
"position": 3,
"name": "Alcools gras",
"item": "https://questionsmedicales.fr/mesh/D005233"
},
{
"@type": "ListItem",
"position": 4,
"name": "Dodécan-1-ol",
"item": "https://questionsmedicales.fr/mesh/D007851"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Dodécan-1-ol - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Dodécan-1-ol",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Dodécan-1-ol",
"description": "Comment détecte-t-on une exposition au dodécan-1-ol ?\nQuels tests sont utilisés pour évaluer la toxicité du dodécan-1-ol ?\nY a-t-il des marqueurs biologiques pour le dodécan-1-ol ?\nQuels symptômes indiquent une intoxication au dodécan-1-ol ?\nComment évaluer l'impact environnemental du dodécan-1-ol ?",
"url": "https://questionsmedicales.fr/mesh/D007851?mesh_terms=Disruptive+Technology&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Dodécan-1-ol",
"description": "Quels sont les effets cutanés du dodécan-1-ol ?\nLe dodécan-1-ol cause-t-il des problèmes respiratoires ?\nPeut-on avoir des réactions allergiques au dodécan-1-ol ?\nQuels symptômes digestifs sont associés au dodécan-1-ol ?\nLe dodécan-1-ol affecte-t-il le système nerveux ?",
"url": "https://questionsmedicales.fr/mesh/D007851?mesh_terms=Disruptive+Technology&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Dodécan-1-ol",
"description": "Comment prévenir l'exposition au dodécan-1-ol ?\nQuelles sont les bonnes pratiques en milieu de travail ?\nDes alternatives au dodécan-1-ol existent-elles ?\nComment stocker le dodécan-1-ol en toute sécurité ?\nQuelles étiquettes de sécurité sont nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D007851?mesh_terms=Disruptive+Technology&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Dodécan-1-ol",
"description": "Quel traitement pour une irritation cutanée due au dodécan-1-ol ?\nComment traiter une intoxication par inhalation de dodécan-1-ol ?\nY a-t-il un antidote pour le dodécan-1-ol ?\nQuels soins d'urgence pour ingestion de dodécan-1-ol ?\nComment gérer une réaction allergique au dodécan-1-ol ?",
"url": "https://questionsmedicales.fr/mesh/D007851?mesh_terms=Disruptive+Technology&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Dodécan-1-ol",
"description": "Quelles complications peuvent survenir après exposition au dodécan-1-ol ?\nLe dodécan-1-ol peut-il causer des maladies chroniques ?\nY a-t-il des effets à long terme de l'exposition au dodécan-1-ol ?\nLe dodécan-1-ol affecte-t-il la reproduction ?\nQuelles sont les conséquences d'une surdose de dodécan-1-ol ?",
"url": "https://questionsmedicales.fr/mesh/D007851?mesh_terms=Disruptive+Technology&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Dodécan-1-ol",
"description": "Qui est le plus à risque d'exposition au dodécan-1-ol ?\nLes enfants sont-ils plus vulnérables au dodécan-1-ol ?\nQuels comportements augmentent le risque d'exposition ?\nLes personnes allergiques sont-elles plus à risque ?\nL'environnement de travail influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D007851?mesh_terms=Disruptive+Technology&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on une exposition au dodécan-1-ol ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition se détecte par des tests de laboratoire sur des échantillons biologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la toxicité du dodécan-1-ol ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de toxicité in vitro et in vivo sont utilisés pour évaluer ses effets."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques pour le dodécan-1-ol ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de marqueurs biologiques spécifiques pour cet alcool."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication au dodécan-1-ol ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent irritation cutanée, nausées et maux de tête."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'impact environnemental du dodécan-1-ol ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études écotoxicologiques sont menées pour évaluer son impact sur les écosystèmes."
}
},
{
"@type": "Question",
"name": "Quels sont les effets cutanés du dodécan-1-ol ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut provoquer des irritations, des rougeurs et des démangeaisons cutanées."
}
},
{
"@type": "Question",
"name": "Le dodécan-1-ol cause-t-il des problèmes respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition excessive peut entraîner des irritations des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des réactions allergiques au dodécan-1-ol ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent développer des allergies cutanées à cet alcool."
}
},
{
"@type": "Question",
"name": "Quels symptômes digestifs sont associés au dodécan-1-ol ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées et des vomissements peuvent survenir après ingestion accidentelle."
}
},
{
"@type": "Question",
"name": "Le dodécan-1-ol affecte-t-il le système nerveux ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition élevée peut causer des maux de tête et des vertiges."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition au dodécan-1-ol ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle lors de la manipulation."
}
},
{
"@type": "Question",
"name": "Quelles sont les bonnes pratiques en milieu de travail ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Assurer une ventilation adéquate et former le personnel sur les risques."
}
},
{
"@type": "Question",
"name": "Des alternatives au dodécan-1-ol existent-elles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, plusieurs autres alcools gras peuvent être utilisés comme substituts."
}
},
{
"@type": "Question",
"name": "Comment stocker le dodécan-1-ol en toute sécurité ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Conserver dans un endroit frais, sec et bien ventilé, loin des sources d'ignition."
}
},
{
"@type": "Question",
"name": "Quelles étiquettes de sécurité sont nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les étiquettes doivent indiquer les risques et les mesures de sécurité à suivre."
}
},
{
"@type": "Question",
"name": "Quel traitement pour une irritation cutanée due au dodécan-1-ol ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est recommandé d'utiliser des crèmes apaisantes et d'éviter l'exposition."
}
},
{
"@type": "Question",
"name": "Comment traiter une intoxication par inhalation de dodécan-1-ol ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il faut évacuer la personne à l'air frais et consulter un médecin si nécessaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il un antidote pour le dodécan-1-ol ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique ; le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Quels soins d'urgence pour ingestion de dodécan-1-ol ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ne pas provoquer le vomissement ; consulter immédiatement un centre antipoison."
}
},
{
"@type": "Question",
"name": "Comment gérer une réaction allergique au dodécan-1-ol ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éliminer l'exposition et administrer des antihistaminiques si nécessaire."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition au dodécan-1-ol ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications cutanées comme des infections peuvent survenir après irritation."
}
},
{
"@type": "Question",
"name": "Le dodécan-1-ol peut-il causer des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut contribuer à des maladies respiratoires chroniques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme de l'exposition au dodécan-1-ol ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent des effets potentiels sur le système nerveux à long terme."
}
},
{
"@type": "Question",
"name": "Le dodécan-1-ol affecte-t-il la reproduction ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études sont nécessaires, mais des effets sur la reproduction n'ont pas été prouvés."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une surdose de dodécan-1-ol ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surdose peut entraîner des symptômes graves, nécessitant une intervention médicale."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'exposition au dodécan-1-ol ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs dans l'industrie chimique et cosmétique sont les plus exposés."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables au dodécan-1-ol ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus sensibles aux effets des produits chimiques."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque d'exposition ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Manipuler sans protection ou utiliser des produits contenant du dodécan-1-ol augmente le risque."
}
},
{
"@type": "Question",
"name": "Les personnes allergiques sont-elles plus à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant des antécédents d'allergies cutanées sont plus à risque."
}
},
{
"@type": "Question",
"name": "L'environnement de travail influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un environnement mal ventilé ou non sécurisé augmente le risque d'exposition."
}
}
]
}
]
}
In this review, we present recent findings and advancements in the use of neuroimaging to evaluate neural activity relative to ACL injury risk and patellofemoral pain. In particular, we describe prior...
Recent studies that utilized both fMRI and EEG indicate that athletes who are at risk for future ACL injury exhibit divergent brain activity both during active lower extremity movement and at rest. Su...
Assisted reproduction technology (ART) has advanced significantly, raising concerns regarding its impact on the secondary sex ratio (SSR), which is the sex ratio at birth in offspring. This study aime...
A retrospective analysis was conducted on data from 8335 births involving 6,223 couples undergoing ART. Binary logistic regression assessed relationships between parental and embryonic factors and SSR...
Secondary infertility (OR = 1.164, 95% CI: 1.009-1.342), advanced paternal age (OR = 1.261, 95% CI: 1.038-1.534), and blastocyst embryo transfer (OR = 1.339, 95% CI: 1.030-1.742) were associated with ...
This study demonstrates the complex interplay of various factors in determining the SSR in ART, highlighting the importance of considering infertility type, paternal age, fertilization method, embryo ...
Digital assistive technologies (eg, applications, wearables and robots) have emerged as promising tools for managing various aspects of daily life, such as basic assistance, encompassing social intera...
We will follow the scoping review framework proposed by Arksey and O'Malley. A comprehensive search will be performed to identify original research articles or clinical trials published between 2013 a...
Ethical approval is not required because this study is a scoping review based on published data. We intend to publish our findings in a peer-reviewed journal....
Scimitar syndrome (SS) is a rare entity with an incidence of approximately 1-3 in 200 000 people. It is typically characterized by complete or partial anomalous pulmonary venous drainage from the righ...
Eye-gaze technology provides access to a computer through the control of eye movements, thus allowing students with severe motor and communication difficulties to communicate and participate in curric...
Additive manufacturing (3D printing) has been deployed across multiple platforms to fabricate bioengineered tissues. We demonstrate the use of a Thermal Inkjet Pipette System (TIPS) for targeted deliv...
Thise research was conducted to determine the impact of the applied casting technology, mould and alloying additives on the tightness of the CuSn10 cast alloy. Under industrial conditions, a series of...
Aided conversations differ from spoken ones in their transitions between turns and symbols because seeking and choosing symbols takes more time than speaking words naturally. This study adopted the co...
Cellular phenotypes and functional responses are modulated by the signals present in their microenvironment, including extracellular matrix (ECM) proteins, tissue mechanical properties, soluble signal...